Joseph A. Tyndall sold $174k of AXGN
director at Axogen, Inc.. 3,500 shares at an average of $49.70, traded Sep 2, 2026, filed Sep 4, 2026.
Score components
- +15RoleDirector
- +11Trade size$174k at market
- +5Share of holdings soldSold 25% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000805928-26-000101, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | SOpen-market sale Common Stock10b5-1 | -3,500 | $49.70 | $174k | 10,650 | 38 d ago |
Related signals
Other insiders at Axogen, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | AXGNsell Axogen, Inc. | Erick Wayne DeVinney Chief Innovation Officer | $19k 1,137 shares | -1% | |
| 49Moderate | Axogen, Inc. | Joseph A. Tyndall director | $289k 26,931 shares | -100% | |
| 41Moderate | Axogen, Inc. | John Johnson director | $43k 4,073 shares | -14% | |
| 36Weak | Axogen, Inc. | Guido J Neels director | $43k 4,073 shares | -4% | |
| 41Moderate | Axogen, Inc. | William P. Mr. Burke director | $43k 4,073 shares | -14% | |
| 36Weak | Axogen, Inc. | Amy McBride Wendell director | $43k 4,073 shares | -4% | |
| 36Weak | Axogen, Inc. | Alan M Levine director | $43k 4,073 shares | -10% | |
| 46Moderate | Axogen, Inc. | Kathy Johnson Weiler director | $43k 4,073 shares | -38% | |
| 25Weak | AXGNsell Axogen, Inc. | Joseph A. Tyndall director | $29k 2,525 shares | -10% | |
| 32Weak | AXGNsell Axogen, Inc. | Joseph A. Tyndall director | $225k 20,062 shares | -57% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.